NCT04935164 Comparative Study of Gender Identity Disorder Versus Control
| NCT ID | NCT04935164 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Henri Laborit |
| Condition | Gender Dysphoria, Adult |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2021-03-26 |
| Primary Completion | 2029-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2021-03-26 with a primary completion date of 2029-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Gender dysphoria is manifested by an internal tension between biological sex and gender, that is, by a non-congruence, in the subjects who suffer from it, between their sex of birth and their social gender identity.
Eligibility Criteria
Inclusion Criteria: * Patients with gender dysphoria * Without psychotropic * Without hormono-therapy * Without sexual surgery assignation Exclusion Criteria: * Any depression * Any addiction
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04935164 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Gender Dysphoria, Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04935164 currently recruiting?
Yes, NCT04935164 is actively recruiting participants. Contact the research team at berangere.thirioux@ch-poitiers.fr for enrollment information.
Where is the NCT04935164 trial being conducted?
This trial is being conducted at Poitiers, France.
Who is sponsoring the NCT04935164 clinical trial?
NCT04935164 is sponsored by Centre Hospitalier Henri Laborit. The trial plans to enroll 120 participants.